Methinks
Methinks AI is a company dedicated to improving stroke treatment accessibility through AI-powered imaging analysis. Their core product focuses on analyzing Non-contrast CT (NCCT) scans, the most universally available imaging method, to rapidly detect Large Vessel Occlusions (LVO) and hemorrhages. This allows for earlier triage and faster treatment decisions in stroke care. The solution integrates with Microsoft Teams for enhanced clinical coordination and scalability. Methinks AI is CE-marked and has been validated in leading hospitals across Europe and the U.S., aiming to transform stroke pathways in various resource settings. The company is also partnering with Medtronic to broaden stroke care access and is involved in the international Done Symple trial focused on late-window stroke treatment.
Methinks
Methinks AI is a company dedicated to improving stroke treatment accessibility through AI-powered imaging analysis. Their core product focuses on analyzing Non-contrast CT (NCCT) scans, the most universally available imaging method, to rapidly detect Large Vessel Occlusions (LVO) and hemorrhages. This allows for earlier triage and faster treatment decisions in stroke care. The solution integrates with Microsoft Teams for enhanced clinical coordination and scalability. Methinks AI is CE-marked and has been validated in leading hospitals across Europe and the U.S., aiming to transform stroke pathways in various resource settings. The company is also partnering with Medtronic to broaden stroke care access and is involved in the international Done Symple trial focused on late-window stroke treatment.
TL;DR
What they do: AI software for early stroke assessment and triage using non-contrast CT (detects LVO and intracerebral hemorrhage)
Regulatory status: Company states its device is CE-marked and FDA-cleared for LVO and intracerebral hemorrhage detection on non-contrast CT
HQ: Barcelona, Spain (operating legal entity: METHINKS SOFTWARE S.L.)
Founder / leadership: Cristian Martí — listed as CSO & Founder (also shown as CEO/Chairman of the Board)
Last round: Convertible Note (lead: European Innovation Council); total funding listed as $5,110,000 (USD)
Company Overview
Problem Domain
Early stroke assessment and triage using CT imaging
Founded
2016
Industry
Healthcare; Medical imaging; AI
Tech Stack
Funding Track Record
Investor Signal
“European Innovation Council listed as lead investor (Convertible Note)”